Suchergebnisse - "Kobbernagel, Helene E"

PubPharm (8)

1

A BEAT-PCD consensus statement : a core outcome set for pulmonary disease interventions in primary ciliary dyskinesia

enthalten in: ERJ open research | 2024

von Kos, R. | Goutaki, M. | Kobbernagel, H. | +23

2

The disease-specific clinical trial network for primary ciliary dyskinesia : PCD-CTN

enthalten in: ERJ open research | 2022

von Raidt, J. | Maitre, B. | Pennekamp, P. | +48

3

Efficacy and safety of azithromycin maintenance therapy in primary ciliary dyskinesia (BESTCILIA) : a multicentre, double-blind, randomised, placebo-controlled phase 3 trial

enthalten in: The Lancet. Respiratory medicine | 2020

von Kobbernagel, H. | Buchvald, F. | Haarman, E. | +14

CommentIn: Lancet Respir Med. 2020 May;8(5):429-430. - PMID 32380064

4

Hypertonic saline in patients with primary ciliary dyskinesia : on the road to evidence-based treatment for a rare lung disease

enthalten in: The European respiratory journal | 2017

von Kuehni, C. | Goutaki, M. | Kobbernagel, H.

CommentOn: Eur Respir J. 2017 Feb 23;49(2):. - PMID 28232410

5

Hypertonic saline in patients with primary ciliary dyskinesia: on the road to evidence-based treatment for a rare lung disease

enthalten in: The European respiratory journal | 2017

von Kuehni, C. | Goutaki, M. | Kobbernagel, H.

6

Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia

enthalten in: BMC pulmonary medicine | 2016

von Kobbernagel, H. | Buchvald, F. | Haarman, E. | +9

7

Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia

enthalten in: BMC pulmonary medicine | 2016

von Kobbernagel, H. | Buchvald, F. | Haarman, E. | +9

8

Study protocol, rationale and recruitment in a European multi-centre randomized controlled trial to determine the efficacy and safety of azithromycin maintenance therapy for 6 months in primary ciliary dyskinesia

enthalten in: BMC pulmonary medicine | 2016

von Kobbernagel, H. | Buchvald, F. | Haarman, E. | +9

1
[1]